Skip to content
DefDex

Federal award

PANTHERA BIOPHARMA, LLC

W81XWH09C0091

Contract

Obligated and Ceiling

Obligated (net)
$1,623,223.00
Ceiling (potential value, not spending)
—
Current value
—
Gross positive obligations
$1,623,223.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
PANTHERA BIOPHARMA, LLC · UFSEPG4LASN7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
PANTHERA BIOPHARMA, LLC · UFSEPG4LASN7
Awarding agency
Department of War · sub-agency 2100 · office W81XWH
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
W81XWH09C0091
Award type code
D
Actions
4 · Jul 1, 2009 to Aug 13, 2015
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History4

Award actions
DateFYModAction typeObligationCompany in company totals
Aug 13, 2015FY2015P00002K$0.00
—
Oct 16, 2014FY2015PK0001M$0.00
—
Feb 1, 2010FY2010P00001M$0.00
—
Jul 1, 2009FY20090—$1,623,223.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.